Carlson P, Korpela J, Walder M, Nyman M
Division of Bacteriology, HUCH Diagnostics, Helsinki University Central Hospital, Finland.
Eur J Clin Microbiol Infect Dis. 1999 Dec;18(12):915-7. doi: 10.1007/s100960050432.
Isolates obtained from the blood of ten patients with Arcanobacterium haemolyticum septicaemia were biotyped as smooth or rough using morphological and biochemical criteria, and their susceptibilities to 18 antibacterial agents were determined. Nine of the clinical cases included here have not been reported previously and are discussed in brief. One of the strains was highly resistant to macrolides and clindamycin. With one exception, the strains belonged to the smooth biotype. The data presented here indicates that the treatment of systemic Arcanobacterium haemolyticum infections should be based on the antibacterial susceptibility profiles of individual strains and on the site of the infection.
从10例溶血隐秘杆菌败血症患者血液中分离出的菌株,根据形态学和生化标准进行生物分型,分为光滑型或粗糙型,并测定了它们对18种抗菌药物的敏感性。这里纳入的9例临床病例此前未曾报道,现作简要讨论。其中一株菌株对大环内酯类和克林霉素高度耐药。除1株外,其余菌株均属于光滑生物型。本文提供的数据表明,全身性溶血隐秘杆菌感染的治疗应基于各菌株的抗菌药敏谱以及感染部位。